PMV Pharmaceuticals snags $70m Series D
Cranbury, New Jersey-based PMV Pharmaceuticals, Inc., a precision oncology company, has closed $70 million in Series D financing.
3 August 2020•1 min read
Cranbury, New Jersey-based PMV Pharmaceuticals, Inc., a precision oncology company, has closed $70 million in Series D financing.